General Info

With over six years of research experience as a leading Principal Investigator and Sub-Investigator, Dr. Naser Elkhalili has participated in multiple studies for indications such as Rheumatoid Arthritis, Lupus Fibromyalgia, and Gout. Dr. Elkhalili and his physician partners are aware of the critical role that a successful research site provides on behalf of sponsors in the drug approval process. This has driven their academic and professional interest in offering clinical trials to our large and diverse Houston population as a treatment option. Our interest is expanding to include such conditions as Type II Diabetes, Multiple Sclerosis, Respiratory, Hypertension, and Women’s Health clinical trials.